Could therapeutic drug monitoring of anti-TNF-α be useful to consider a de-escalation of treatment?
- 期刊名称Expert Opinion on Biological Therapy
- 作者Flamant, Mathurin; Roblin, Xavier
- 卷第15卷
- 期第11期
- 印刷ISSN1471-2598
- 电子ISSN1744-7682
- 文件大小507.13KB
- 发表时间2015-11-02
- DOI10.1517/14712598.2015.1069273
- 页码1657-1660
Current ebola vaccinesHoenen, Thomas; Groseth, Allison; Feldmann, Heinz · Expert Opinion on Biological Therapy · 2012
Preventative childhood vaccination to rabiesLiu, Qin; Ertl, Hildegund CJ · Expert Opinion on Biological Therapy · 2012
Designing immunoconjugates for cancer therapyGovindan, Serengulam V; Goldenberg, David M · Expert Opinion on Biological Therapy · 2012
Bevacizumab treatment of prostate cancerSmall, Alexander C; Oh, William K · Expert Opinion on Biological Therapy · 2012
Hydrodynamic delivery of DNAHodges, Bradley L; Scheule, Ronald K · Expert Opinion on Biological Therapy · 2003
Circulating nucleic acids and evolutionAnker, Philippe; Stroun, Maurice · Expert Opinion on Biological Therapy · 2012
Novel neural stem cell systemsConti, Luciano; Cattaneo, Elena; Papadimou, Evangelia · Expert Opinion on Biological Therapy · 2008
HSV-1 amplicon vectorsCuchet, Delphine; Potel, Corinne; Thomas, Joélle; Epstein, Alberto L · Expert Opinion on Biological Therapy · 2007